
zzso zzso zzso is an active zzso for advanced zzso cell lung zzso zzso has a narrow therapeutic index and may produce a cumulative zzso over the treatment zzso This study was to assess the risks of zzso interaction zzso over 3 consecutive cycles of zzso combined zzso 

An zzso zzso phase I study was carried zzso Patients with normal zzso zzso zzso zzso 100 zzso zzso oral zzso 60 zzso zzso zzso zzso over the first 3 zzso zzso comparison between cycles and between study zzso zzso 

Thirteen patients were zzso for safety and zzso zzso events were those frequently observed with zzso or zzso and consisted of zzso zzso zzso vomiting and zzso zzso zzso and zzso zzso no difference was detected between the 3 administrations nor between the study and reference zzso 

The absence of zzso between zzso and oral zzso was demonstrated over 3 consecutive cycles of zzso 

